Résultats de la recherche

search

Rechercher les filtres

Organisation
Radiance BioPharma
Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate
19 févr. 2025 13h29 HE | Radiance BioPharma
BOSTON, Massachusetts, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or the "Company"), a biotechnology company, today announced that it has entered into an exclusive...
Radiance has been selected to Present at the 2025 Biotech Showcase™ Alongside the J.P. Morgan Healthcare Conference
15 janv. 2025 16h50 HE | Radiance BioPharma
BOSTON, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. a biotechnology company developing next generation Antibody Drug Conjugates (“ADCs”) and Bispecific ADCs (“BsADCs), announced that...
Radiance BioPharma sponsoring Investor Cruise Event 2024
29 août 2024 15h30 HE | Radiance BioPharma
BOSTON, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Radiance Biopharma Inc., a biopharmaceutical company developing next generation Antibody Drug Conjugates and Bispecific Antibody Drug Conjugates announced...